Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With Neovascular (Wet) Age-related Macular Degeneration (nAMD)

NCT06346600 is registered in ClinicalTrials.gov with Skyline Therapeutics as lead sponsor.

NCT NCT06346600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06346600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With Neovascular (Wet) Age-related Macular Degeneration (nAMD)
Lead sponsor
Skyline Therapeutics
Phase
Observational
Overall status
Recruiting
Start date
April 2, 2025
Completion date
March 31, 2031
Enrollment
83 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular (wet) age-related macular degeneration